Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8731 |
High Similarity |
NPD1510 |
Phase 2 |
0.8712 |
High Similarity |
NPD1240 |
Approved |
0.8712 |
High Similarity |
NPD943 |
Approved |
0.8676 |
High Similarity |
NPD1549 |
Phase 2 |
0.8603 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8603 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD1607 |
Approved |
0.8321 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7986 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7947 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7947 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD1934 |
Approved |
0.791 |
Intermediate Similarity |
NPD1164 |
Approved |
0.791 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7879 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7869 |
Intermediate Similarity |
NPD1237 |
Approved |
0.7867 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7808 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7763 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.776 |
Intermediate Similarity |
NPD9266 |
Approved |
0.776 |
Intermediate Similarity |
NPD74 |
Approved |
0.7756 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7733 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7703 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7697 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7687 |
Intermediate Similarity |
NPD5401 |
Approved |
0.768 |
Intermediate Similarity |
NPD9267 |
Approved |
0.768 |
Intermediate Similarity |
NPD9264 |
Approved |
0.768 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7655 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7557 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7547 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7519 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7516 |
Intermediate Similarity |
NPD2801 |
Approved |
0.75 |
Intermediate Similarity |
NPD5408 |
Approved |
0.75 |
Intermediate Similarity |
NPD5404 |
Approved |
0.75 |
Intermediate Similarity |
NPD5406 |
Approved |
0.75 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7468 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7465 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7419 |
Intermediate Similarity |
NPD940 |
Approved |
0.7419 |
Intermediate Similarity |
NPD846 |
Approved |
0.7413 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7388 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7351 |
Intermediate Similarity |
NPD920 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7317 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7248 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7472 |
Approved |
0.723 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7203 |
Intermediate Similarity |
NPD520 |
Approved |
0.72 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD9717 |
Approved |
0.717 |
Intermediate Similarity |
NPD5494 |
Approved |
0.716 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7113 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD919 |
Approved |
0.7092 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD3400 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.705 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2654 |
Approved |
0.6993 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.697 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6933 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD1613 |
Approved |
0.6918 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD3751 |
Discontinued |
0.688 |
Remote Similarity |
NPD2860 |
Approved |
0.688 |
Remote Similarity |
NPD2859 |
Approved |
0.6879 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6855 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6846 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6842 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6828 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6815 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6815 |
Remote Similarity |
NPD3226 |
Approved |
0.68 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.68 |
Remote Similarity |
NPD2933 |
Approved |
0.68 |
Remote Similarity |
NPD2934 |
Approved |
0.68 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6795 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6781 |
Remote Similarity |
NPD3268 |
Approved |
0.6781 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6772 |
Remote Similarity |
NPD9495 |
Approved |
0.6767 |
Remote Similarity |
NPD4750 |
Phase 3 |
0.6766 |
Remote Similarity |
NPD6020 |
Phase 2 |
0.6759 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6757 |
Remote Similarity |
NPD447 |
Suspended |
0.6755 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6755 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6733 |
Remote Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.6733 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6732 |
Remote Similarity |
NPD1196 |
Approved |
0.6726 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6719 |
Remote Similarity |
NPD3020 |
Approved |
0.6713 |
Remote Similarity |
NPD1876 |
Approved |
0.671 |
Remote Similarity |
NPD1543 |
Discontinued |
0.6709 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6705 |
Remote Similarity |
NPD6534 |
Approved |
0.6705 |
Remote Similarity |
NPD6535 |
Approved |
0.669 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.669 |
Remote Similarity |
NPD9494 |
Approved |
0.6689 |
Remote Similarity |
NPD6100 |
Approved |
0.6689 |
Remote Similarity |
NPD6099 |
Approved |
0.6688 |
Remote Similarity |
NPD2354 |
Approved |
0.6688 |
Remote Similarity |
NPD3887 |
Approved |
0.6667 |
Remote Similarity |
NPD1195 |
Approved |
0.6667 |
Remote Similarity |
NPD4661 |
Approved |
0.6667 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6667 |
Remote Similarity |
NPD2797 |
Approved |
0.6667 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD4662 |
Approved |
0.6667 |
Remote Similarity |
NPD411 |
Approved |
0.6667 |
Remote Similarity |
NPD5711 |
Approved |
0.6667 |
Remote Similarity |
NPD5710 |
Approved |
0.6667 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6644 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6644 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6644 |
Remote Similarity |
NPD1933 |
Approved |
0.6625 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.662 |
Remote Similarity |
NPD1535 |
Discovery |
0.6611 |
Remote Similarity |
NPD6778 |
Approved |
0.6611 |
Remote Similarity |
NPD6780 |
Approved |
0.6611 |
Remote Similarity |
NPD6782 |
Approved |
0.6611 |
Remote Similarity |
NPD6781 |
Approved |
0.6611 |
Remote Similarity |
NPD6777 |
Approved |
0.6611 |
Remote Similarity |
NPD6776 |
Approved |
0.6611 |
Remote Similarity |
NPD6779 |
Approved |
0.6605 |
Remote Similarity |
NPD2296 |
Approved |
0.6605 |
Remote Similarity |
NPD4288 |
Approved |
0.6604
|
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |